SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-005571
Filing Date
2018-11-14
Accepted
2018-11-14 16:54:50
Documents
77
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 447721
2 CERTIFICATION curr_ex311.htm EX-31.1 8841
3 CERTIFICATION curr_ex312.htm EX-31.2 9661
4 CERTIFICATION curr_ex321.htm EX-32.1 3643
5 CERTIFICATION curr_ex322.htm EX-32.2 3545
  Complete submission text file 0001477932-18-005571.txt   4352676

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20180930.xml EX-101.INS 853511
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20180930.xsd EX-101.SCH 65365
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20180930_cal.xml EX-101.CAL 55096
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20180930_def.xml EX-101.DEF 220660
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20180930_lab.xml EX-101.LAB 331968
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20180930_pre.xml EX-101.PRE 325667
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 181184833
SIC: 2673 Plastics, Foil & Coated Paper Bags
Assistant Director 6